Growth Metrics

MeiraGTx Holdings (MGTX) Research & Development (2017 - 2025)

MeiraGTx Holdings posted quarterly Research & Development of $30.8 million for Q4 2025, up 28.46% year-on-year from $24.0 million in Q4 2024, and down 5.29% on a QoQ basis from $32.5 million in Q3 2025.

MeiraGTx Holdings (MGTX) has 9 years of Research & Development data on file, last reported at $30.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 28.46% year-over-year to $30.8 million; the trailing twelve-month figure through Dec 2025 stood at $129.6 million (up 8.48% YoY), and the FY2025 full-year result was $129.6 million, up 8.48% from the prior year.
  • Research & Development for Q4 2025 stood at $30.8 million, down from $32.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $34.9 million in Q2 2024 and bottomed at $13.2 million in Q4 2021.
  • The 5-year median for Research & Development is $24.0 million (2022), against an average of $25.3 million.
  • The widest annual swing landed in 2021, when Research & Development surged 367.21%; it then decreased 28.76% in 2024.
  • A 5-year view of Research & Development shows it stood at $13.2 million in 2021, then surged by 65.11% to $21.8 million in 2022, then surged by 54.7% to $33.7 million in 2023, then fell by 28.76% to $24.0 million in 2024, then grew by 28.46% to $30.8 million in 2025.
  • The last three Research & Development figures came in at $30.8 million (Q4 2025), $32.5 million (Q3 2025), and $33.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 626,092.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 4.32 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -101.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 1.46 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 961.60 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -2.30 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 1.54 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 364.87 Mn
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 30.81 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 30.81 Mn
Sep 30, 2025 32.53 Mn
Jun 30, 2025 33.50 Mn
Mar 31, 2025 32.78 Mn
Dec 31, 2024 23.99 Mn
Sep 30, 2024 26.24 Mn
Jun 30, 2024 34.93 Mn
Mar 31, 2024 34.32 Mn
Dec 31, 2023 33.67 Mn
Sep 30, 2023 27.86 Mn
Jun 30, 2023 19.94 Mn
Mar 31, 2023 22.32 Mn
Dec 31, 2022 21.77 Mn
Sep 30, 2022 16.86 Mn
Jun 30, 2022 24.00 Mn
Mar 31, 2022 23.10 Mn
Dec 31, 2021 13.18 Mn
Sep 30, 2021 21.61 Mn
Jun 30, 2021 15.19 Mn
Mar 31, 2021 16.71 Mn
Dec 31, 2020 5.00 Mn
Sep 30, 2020 4.63 Mn
Jun 30, 2020 16.20 Mn
Mar 31, 2020 8.08 Mn
Dec 31, 2019 -2.49 Mn
Sep 30, 2019 4.61 Mn
Jun 30, 2019 9.77 Mn
Mar 31, 2019 12.98 Mn
Dec 31, 2018 10.79 Mn
Sep 30, 2018 8.11 Mn
Jun 30, 2018 7.79 Mn
Mar 31, 2018 6.93 Mn
Dec 31, 2017 5.78 Mn
Sep 30, 2017 6.39 Mn
Jun 30, 2017 5.36 Mn